142 related articles for article (PubMed ID: 37823255)
21. Sex Differences in Patients With Suspected Cardiac Sarcoidosis Assessed by Cardiovascular Magnetic Resonance Imaging.
Kalra R; Malik S; Chen KA; Ogugua F; Athwal PSS; Elton AC; Velangi PS; Ismail MF; Chhikara S; Markowitz JS; Nijjar PS; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
Circ Arrhythm Electrophysiol; 2021 Sep; 14(9):e009966. PubMed ID: 34546787
[TBL] [Abstract][Full Text] [Related]
22. Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy.
Nakasuka K; Ishibashi K; Hattori Y; Mori K; Nakajima K; Nagayama T; Kamakura T; Wada M; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Takaya Y; Isobe M; Terasaki F; Ohte N; Kusano K
Heart Rhythm; 2022 Jul; 19(7):1133-1140. PubMed ID: 35257978
[TBL] [Abstract][Full Text] [Related]
23. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
Nordenswan HK; Lehtonen J; Ekström K; Räisänen-Sokolowski A; Mäyränpää MI; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
J Am Heart Assoc; 2021 Mar; 10(6):e019415. PubMed ID: 33660520
[TBL] [Abstract][Full Text] [Related]
24. Predictors of appropriate implantable cardiac defibrillator therapy in cardiac sarcoidosis.
Mathijssen H; Bakker ALM; Balt JC; Akdim F; van Es HW; Veltkamp M; Grutters JC; Post MC
J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1272-1280. PubMed ID: 35411644
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Predictors of Relapse After Weaning Immune Suppressive Therapy in Cardiac Sarcoidosis.
Arps K; Doss J; Geiger K; Flores-Rosario K; DeVore AD; Karra R; Kim HW; Piccini JP; Pokorney SD; Sun AY
Am J Cardiol; 2023 Oct; 204():249-256. PubMed ID: 37556894
[TBL] [Abstract][Full Text] [Related]
26. Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes.
Duvall C; Pavlovic N; Rosen NS; Wand AL; Griffin JM; Okada DR; Tandri H; Kasper EK; Sharp M; Chen ES; Chrispin J; Gilotra NA
J Card Fail; 2023 Aug; 29(8):1135-1145. PubMed ID: 37062472
[TBL] [Abstract][Full Text] [Related]
27. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis.
Shafee MA; Fukuda K; Wakayama Y; Nakano M; Kondo M; Hasebe Y; Kawana A; Shimokawa H
J Cardiol; 2012 Dec; 60(6):448-53. PubMed ID: 22944174
[TBL] [Abstract][Full Text] [Related]
28. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490
[TBL] [Abstract][Full Text] [Related]
29. Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.
Gilotra NA; Griffin JM; Pavlovic N; Houston BA; Chasler J; Goetz C; Chrispin J; Sharp M; Kasper EK; Chen ES; Blankstein R; Cooper LT; Joyce E; Sheikh FH
J Card Fail; 2022 Jan; 28(1):113-132. PubMed ID: 34260889
[TBL] [Abstract][Full Text] [Related]
30. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.
Kandolin R; Lehtonen J; Airaksinen J; Vihinen T; Miettinen H; Ylitalo K; Kaikkonen K; Tuohinen S; Haataja P; Kerola T; Kokkonen J; Pelkonen M; Pietilä-Effati P; Utrianen S; Kupari M
Circulation; 2015 Feb; 131(7):624-32. PubMed ID: 25527698
[TBL] [Abstract][Full Text] [Related]
31. Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample.
Taduru SS; Goyal A; Dalia T; Mastoris I; Rali AS; Acharya P; Weidling R; Sauer A; Haglund N; Shah Z
Indian Heart J; 2022; 74(2):148-150. PubMed ID: 35104459
[TBL] [Abstract][Full Text] [Related]
32. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
[TBL] [Abstract][Full Text] [Related]
34. FDG uptake patterns in isolated and systemic cardiac sarcoidosis.
Kaneko K; Nagao M; Yamamoto A; Sakai A; Sakai S
J Nucl Cardiol; 2023 Jun; 30(3):1065-1074. PubMed ID: 36192524
[TBL] [Abstract][Full Text] [Related]
35. High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement.
Baba Y; Kubo T; Ochi Y; Hirota T; Yamasaki N; Ohnishi H; Kubota T; Yokoyama A; Kitaoka H
Intern Med; 2023 Nov; 62(21):3097-3105. PubMed ID: 36927971
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Cardiac Sarcoidosis in Middle-Aged Adults Diagnosed with High-Grade Atrioventricular Block.
Maizels L; Mansour M; Abu-Much A; Massalha E; Kalstein M; Beinart R; Sabbag A; Brodov Y; Goitein O; Chernomordik F; Berger M; Herscovici R; Kuperstein R; Arad M; Matetzky S; Beigel R
Am J Med; 2024 Apr; 137(4):358-365. PubMed ID: 38113953
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
39. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
40. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings.
Kusano K; Ishibashi K; Noda T; Nakajima K; Nakasuka K; Terasaki S; Hattori Y; Nagayama T; Mori K; Takaya Y; Miyamoto K; Nagase S; Aiba T; Yasuda S; Kitakaze M; Kamakura S; Yazaki Y; Morimoto SI; Isobe M; Terasaki F
JACC Asia; 2021 Dec; 1(3):385-395. PubMed ID: 36341209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
